Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thromboembolic Risk Screening in Patients With Cancer and COVID-19

NCT04616846 is registered in ClinicalTrials.gov with Centre Antoine Lacassagne as lead sponsor.

NCT NCT04616846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04616846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thromboembolic Risk Screening in Patients With Cancer and COVID-19
Lead sponsor
Centre Antoine Lacassagne
Phase
Not applicable
Overall status
Completed
Start date
August 4, 2020
Completion date
January 25, 2022
Enrollment
88 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, neoplasms malignant, thromboembolism